Cell Therapeutics (CTIC)
Cell Therapeutics Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Research & Development Expense | 8.17M | 7.918M | 7.53M | 7.958M | 11.49M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 9.928M | 12.99M | 7.76M | 8.961M | 8.576M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | 0.11M | 0.129M | 0.14M | 0.167M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 18.10M | 10.02M | 15.42M | 17.06M | 20.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -18.10M | -10.02M | -15.42M | -17.06M | -20.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.569M | 0.974M | -1.308M | 0.018M | 0.433M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -17.53M | -9.047M | -16.73M | -17.04M | -19.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -17.53M | -9.047M | -16.73M | -17.04M | -19.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -17.53M | -9.047M | -16.73M | -17.04M | -19.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -17.45M | -17.87M | -29.68M | -22.51M | -51.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 203.96 | 171.47 | 185.00 | 165.37 | 146.38 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 203.96 | 171.47 | 185.00 | 165.37 | 146.38 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.09 | -0.06 | -0.16 | -0.14 | -0.35 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.09 | -0.06 | -0.16 | -0.14 | -0.35 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
